Clinical Trial: Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055893) titled 'Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen' on May 27.

Brief Summary: To demonstrate the immunogenicity of Sinovac rabies vaccine is non-inferior to the active-controlled rabies vaccine (Verorab(R)) after post-exposure prophylaxis (PEP) vaccination, and to confirm its satisfying safety profile in the pediatric and adult population in a PEP schedule

Study Start Date: March 01, 2026

Study Type: INTERVENTIONAL

Condition: Rabies (Healthy Volunteers)

Intervention: BIOLOGICAL: Rabies vaccine

Receiving five doses of rabies vaccine manufactured by Sinovac using ...